Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian702000Chief Executive Officer & Director
Jeffrey Farber562003Chairman
Martin P. Galvan, CPA652011CFO, Treasurer & Vice President-Finance
Robert Ehlinger602006Chief Information Officer & VP-logistics
Kristin A. Arnold, PhD-2017Vice President-Research & Development
David A. Drabik482010Lead Independent Director
Paul Taveira572012Independent Director
James M. Maher642013Independent Director
Albert R. Paonessa III562015Independent Director
Kevin R. Smith562002Senior Vice President-Sales & Marketing
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,837,305 27,278,394 72.1% 606,734 1.6% 72.1%
Shareholders
NameEquities%
Telemus Capital LLC 6,110,620 16.4%
Jeffrey Farber 4,643,874 12.5%
David Farber 3,779,904 10.2%
BlackRock Fund Advisors 3,663,407 9.84%
Snow Capital Management LP 3,093,435 8.31%
The Vanguard Group, Inc. 2,733,431 7.34%
Deerfield Management Company LP 1,853,896 4.98%
LSV Asset Management 1,691,935 4.54%
Invesco PowerShares Capital Management LLC 1,444,811 3.88%
Morgan Stanley & Co. LLC 1,313,572 3.53%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.743
JOHNSON & JOHNSON18.42%367 520
NOVARTIS12.96%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
SANOFI14.27%123 860
BAYER22.97%112 730
GLAXOSMITHKLINE9.38%106 833
BRISTOL-MYERS SQUIBB C..-3.08%93 311
ELI LILLY AND COMPANY14.06%92 560
NOVO NORDISK A/S15.43%86 701
ASTRAZENECA21.71%86 691
ABBOTT LABORATORIES27.78%85 167
ALLERGAN PLC17.67%82 778
SHIRE-3.53%52 013
TAKEDA PHARMACEUTICAL ..18.99%40 858
TEVA PHARMACEUTICAL IN..-19.60%32 234
ASTELLAS PHARMA INC-13.59%26 111
CHUGAI PHARMACEUTICAL ..24.74%21 041
MYLAN NV2.31%20 919
Sector Pharmaceuticals - NEC
Lannett Company, Inc. : Connections
The American Institute of Certified Public Accountants
National Response Corp.
Kremers Urban Pharmaceuticals, Inc.
Auburn Pharmaceuticals, Inc.
Cranbrook & Co. Llc
Grason-Stadler, Inc.
Generic Pharmaceutical Co.
Company contact information
Lannett Co., Inc.
9000 State Road
Philadelphia, PA 19136

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2017 People , Fundamentals and Ownership